Trial Profile
A phase IIb trial of NMI 900 in patients with advanced ovarian cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs NMI 900 (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 11 May 2016 This trial is expected to initiate in mid-2016, as reported in a Nemucore Medical Innovations media release.
- 10 Dec 2015 New trial record